Explore 3 Stock Ideas & Industry Insights Download Free Report

News

NorthStar Earth & Space Q3 2026: $237.4M Trust, Net Loss

NorthStar Earth & Space Enterprises, Inc. (formerly Viking Acquisition Corp. I) filed its Form 10-Q for the quarter ended September 30, 2026, with the SEC on November 12, 2026, reporting a net loss of $213,504 for the three-month period and total assets of $237,677,451.

Anjali Anand | 12 November 2026

Erasca Q3 2026: Net Loss $51.3M, Two Equity Offerings Raise Over $836M

Erasca, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 12, 2026, reporting a net loss of $51.3 million for the third quarter and disclosing two underwritten common stock offerings completed …

Manish Choudhary | 12 November 2026

Brightline Interactive Posts $1.44M Net Loss for Q1 FY2027

Brightline Interactive, Inc./NV filed a Form 10-Q with the SEC on November 12, 2026, covering the quarterly period ended September 30, 2026, reporting a net loss of $1,436,789 and zero revenue from continuing operations.

Nitish Kishor | 12 November 2026

Universal Logistics Q3 2026: Net Income $18.1M vs Prior-Year Loss

Universal Logistics Holdings, Inc. filed its Form 10-Q for the quarterly period ended October 3, 2026, with the SEC on November 12, 2026, reporting a return to profitability in the third quarter compared to a significant net loss in the same period a year …

Vinay Lochav | 12 November 2026

Fractyl Health Files Q3 2026 Report After Oct. Reprioritization

Fractyl Health, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 12, 2026, disclosing a strategic reprioritization adopted on October 21, 2026 that included a workforce reduction.

Shwetambri Chauhan | 12 November 2026

United States Antimony Q3 2026: $9.5M Net Loss Reported

United States Antimony Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 12, 2026, reporting a net loss of $9,526,056 for the three months ended September 30, 2026.

Nitish Kishor | 12 November 2026

Jerash Holdings Q2 FY2027: Revenue Hits $50.3M

Jerash Holdings (US), Inc. filed its Form 10-Q with the SEC on November 12, 2026, covering the quarterly period ended September 30, 2026, reporting second-quarter and first-half financial results for fiscal year 2027.

Aditi Sarkar | 12 November 2026

Elite Pharmaceuticals Posts $23.2M Net Income for Q2 FY2027

Elite Pharmaceuticals, Inc. filed a Form 10-Q with the SEC on November 12, 2026, covering the quarterly period ended September 30, 2026, reporting condensed consolidated financial results for the three and six months ended on that date.

Vinay Lochav | 12 November 2026

EyePoint Q3 2026: $274.9M Nine-Month Net Loss Reported

EyePoint, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 12, 2026, reporting a net loss of $95.6 million for the third quarter and $274.9 million for the nine months ended September 30, 2026.

Aditi Sarkar | 12 November 2026

Relmada Therapeutics Q3 2026: Net Loss Widens to $13.9M

Relmada Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended September 30, 2026, disclosing a net loss of $13,862,188 for the third quarter and total assets of $205,296,615 as of that date.

Vinay Lochav | 12 November 2026
Support

Hi! How can we help you today?

Loading…